'''Tritoqualine''', also known as '''hypostamine''', is an [[enzyme_inhibitor|inhibitor]] of the [[enzyme]] [[histidine decarboxylase]] and therefore an atypical [[antihistamine]], used for the treatment of [[urticaria]] and allergic [[rhinitis]]<ref>[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W8N-48N2FXH-6&_user=10&_coverDate=04%2F30%2F2003&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_searchStrId=1686147202&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=31a17c7d9173195401b6ca3cd672f02d&searchtype=a Randomized, placebo controlled study of tritoqualine (hypostamine*) in the treatment of perennial allergic rhinitis]. A. Pradalier, V. Hentschel, S. Prouzeau, D. Legallais, G. Lefrançois. Revue Française d’Allergologie et d’Immunologie Clinique 43:175-179 (2003)</ref> with no known adverse effects.{{fact|date=December 2013}}
